跳到主要导航 跳到搜索 跳到主要内容

Research on pharmacokinetics of high-dose tamoxifen in non-small cell lung cancer patients

  • Ling Chen
  • , Xu Li
  • , Rong Li
  • , Xinhan Zhao
  • , Rui Li
  • , Xiaohui Zheng
  • , Sicen Wang
  • Xi'an Jiaotong University

科研成果: 期刊稿件 › 文章 › 同行评审

摘要

Objective: To study the pharmacokinetics of tamoxifen at a high dosage, which will offer a theoretical support for an appropriate clinical use of the medicine in non-small cell lung cancer (NSCLC) patients. Methods: Three qualified NSCLC patients are selected and given tamoxifen (TAM) 160 mg per Os. Blood samples were collected at different times and then analyzed by high-performance liguid chromatography. The PK-GRAPH program was used to obtain the parameters. Results: The concentration-time courses of the TAM 160 mg were fitted to one-compartment model. The pharmacokinetic parameters were estimated as follows: Tmax (6.35 ± 1.24) h, Cmax (217.39 ± 7.71) ng/mL, AUC (12 127.39 ± 636.16) ng·h/mL and T 1/2ke (34.13 ± 2.97) h. Conclusion TAM 160mg one day per Os cannot reach the effective maintenance concentration in vivo required for reversing MDR in vitro. Loading-maintenance dose strategy is recommended to study the pharmacodynamics of tamoxifen at a high dosage in NSCLC patients.

源语言英语
页(从-至)204-207
页数4
期刊Academic Journal of Xi'an Jiaotong University
卷19
期2
出版状态已出版 - 11月 2007

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Research on pharmacokinetics of high-dose tamoxifen in non-small cell lung cancer patients' 的科研主题。它们共同构成独一无二的学术指纹。

引用此